Pharmacokinetics of Dabrafenib in Subjects With Renal Impairment
Clinical trial NCT02852239 · COMPLETED
Trial details
- NCT number
- NCT02852239
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-19
- Primary completion
- 2019-09-27
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.